lung adenocarcinoma

Open Access
A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice
NAN JU, HIROKI HAYASHI, CHINYANG CHANG, HIRONORI NAKAGAMI, RYUICHI MORISHITA and MUNEHISA SHIMAMURA

Anticancer Research June 2026, 46 (6) 3033-3045; DOI: https://doi.org/10.21873/anticanres.18178
You have access
Targeting AURKB Attenuates Tumor Growth in MYC-driven Lung Adenocarcinoma
JANG-HYUK YUN, SEONGKYEONG YOO, YOORIM NOH, JUNGYU SONG, WOO JUNG SON, JIN JU LEE and ILJIN KIM

Anticancer Research June 2026, 46 (6) 3079-3090; DOI: https://doi.org/10.21873/anticanres.18182
Open Access
BIT1 as an Effector of EGFR-TKI-induced Apoptosis via TLE1 Inhibition in Lung Adenocarcinoma Cells
MA CARMELA DELA CRUZ, XIN YAO, ALAJAH NEALY, JAMES BAILEY, MICAH NALLS, PAUL MARK MEDINA, RENWEI CHEN and HECTOR BILIRAN

Anticancer Research April 2026, 46 (4) 1799-1818; DOI: https://doi.org/10.21873/anticanres.18075
You have access
TTF-1 Expression and Efficacy of Platinum and Pemetrexed Plus Pembrolizumab in Advanced Lung Adenocarcinoma
YOSUKE TAMURA, SHIGERU KAWABATA, RYUTARO YAMAGUCHI, YUKI ASAI, SHOICHI ISHIKAWA, KAZUHIRO TAKEZAKI, HIDEAKI KAWAGUCHI, AKIRA YURA, YASUYUKI SHIMAZU, MASAHIRO ARAI, SHO MITSUYA, TOMOYA FUNAMOTO, HIROYUKI TSUJI, NINSO MATSUNAGA, KENJIRO TSURUOKA, TAKAHIKO NAKAMURA, SOICHIRO IKEDA and YASUHITO FUJISAKA

Anticancer Research January 2026, 46 (1) 447-456; DOI: https://doi.org/10.21873/anticanres.17958
You have access
Potential Role of Tumor-derived MIF in B-Cell Antigen Presentation in Lung Adenocarcinoma: Single-cell and TCGA Analyses
FIROZ AHMED and SHAWEZ KHAN

Anticancer Research December 2025, 45 (12) 5369-5387; DOI: https://doi.org/10.21873/anticanres.17874
You have access
Down-regulation of SMPDL3B Inhibits the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells
JAE WOONG KOH and SEON-JOO PARK

Anticancer Research August 2025, 45 (8) 3275-3286; DOI: https://doi.org/10.21873/anticanres.17688
You have access
Activation of the γ-Aminobutyric Acid Receptor Type B Suppresses the Proliferation of Lung Adenocarcinoma Cells
YUBIN ZHOU, KULLANAT KHAWKHIAW, KANYARAT THITHUAN and CHARUPONG SAENGBOONMEE

Anticancer Research April 2025, 45 (4) 1513-1523; DOI: https://doi.org/10.21873/anticanres.17533
You have access
MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
MINJI KWON, DAYEON LIM, JAYEON PARK, WORLD GIL, JIWOO JUNG, SUYEON JUNG, CHAEEON KIM, MINJEONG GO, YE HWANG CHEONG, HEE SUN PARK, YONG-BIN EOM and SIN-AYE PARK

Anticancer Research October 2024, 44 (10) 4283-4299; DOI: https://doi.org/10.21873/anticanres.17258
You have access
Potential Anti-tumor Properties of PDIA4 in Lung Adenocarcinoma
HYEON JI KIM and DO-YEON KIM

Anticancer Research October 2024, 44 (10) 4309-4315; DOI: https://doi.org/10.21873/anticanres.17260
You have access
Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM and HYUN WOO LEE

Anticancer Research May 2024, 44 (5) 2081-2089; DOI: https://doi.org/10.21873/anticanres.17012

Main menu

User menu

Search

lung adenocarcinoma

Pages